| Product Name | MF | CAS | Details |
|---|
| ACOT8 protein (His tag) | Details |
| Ac-NRRRRWRERQR-NH2 | Details |
| Bicyclo[4.1.0]hepta-1,3,5-triene | C7H6 | 4646-69-9 | Details |
| 2-Bromo-3'-bromoacetophenone | C8H6Br2O | 18523-22-3 | Details |
| 1-Benzylpiperazine-2-carbonitrile | C12H15N3 | 947726-96-7 | Details |
| 6-Chloro-2,8-dimethylimidazo[1,2-b]pyridazine | C8H8ClN3 | 17412-23-6 | Details |
| Tolvaptan - Bio-X ? | C26H25ClN2O3 | 150683-30-0 | Details |
| EOS antibody | Details |
| 1-(5-Chlorothiophene-2-carbonyl)piperidine-4-carboxylic acid | C11H12ClNO3S | 1054003-08-5 | Details |
| C.I.Reactive Orange 5 | C26H17ClN7Na3O10S3 | 70210-21-8 | Details |
| (±)-Lariciresinol | C20H24O6 | 105367-81-5 | Details |
| Complement C3 protein | Details |
| Triethyloxonium tetrafluoroborate | C6H15BF4O | 368-39-8 | Details |
| 5-Ethyl-3-morpholinone | C6H11NO2 | 77605-88-0 | Details |
| 2-(Thian-4-yl)acetic acid | C7H12O2S | 137103-09-4 | Details |
| trans,trans-Farnesyl thiosalicylic acid | C22H30O2S | 162520-00-5 | Details |
| (1R)-1-(1,2,3,4-Tetrahydronaphthalen-1-yl)ethan-1-amine | C12H17N | 851984-50-4 | Details |
| 3-(4-Hydroxyphenyl)-1H-pyrazole-5-carboxylic acid | C10H8N2O3 | 1093649-88-7 | Details |
| (4-methoxyphenyl)-N-(3-methyl-4-oxo(2,3,5-thiadiazolinyl))formamide | C11H11N3O3S | 138712-82-0 | Details |
| 2-Hydroxy-4-{[(1-methyl-1H-pyrazol-3-yl)methyl]amino}benzoic acid | C12H13N3O3 | 1006465-90-2 | Details |
| (3-Bromopyridin-2-yl)methanamine | C6H7BrN2 | 1053053-92-1 | Details |
| 4-Chloro-2-hydroxy-1H-imidazo[4,5-c]pyridine | C6H4ClN3O | 54221-73-7 | Details |
| 3-(N-(2-methoxyethyl)carbamoyl)pyridine-2-carboxylic acid | C10H12N2O4 | 497083-21-3 | Details |
| 4-Oxo-4H,5H,6H,7H,8H-furo[3,2-c]azepine-2-carboxylic acid | C9H9NO4 | 2225144-77-2 | Details |
| 3-[(tert-Butyldimethylsilyl)oxy]phenol | C12H20O2Si | 161006-18-4 | Details |
| Val-Asp-(Arg8)-Vasopressin | C55H78N16O17S2 | Details |
| 2-Chloro-N-(2-methyl-2-phenylpropyl)acetamide | C12H16ClNO | 30572-80-6 | Details |
| 1-(3-Chloro-5-fluorophenyl)-2,2-difluoroethan-1-one | C8H4ClF3O | 1352208-84-4 | Details |
| PSMB8 antibody | Details |
| MSK1 antibody (Ser376) | Details |
| CDK5R2 antibody | Details |
| Mas7 | C67H124N18O15 | 145854-59-7 | Details |
| 4-Fluoro-1H-indazole-6-carbonitrile | C8H4FN3 | 1082041-49-3 | Details |
| 4-(Morpholin-4-yl)-N-(propan-2-yl)aniline | C13H20N2O | 13143-61-8 | Details |
| Iron(III) nitrate nonahydrate | FeH18N3O18 | 7782-61-8 | Details |
| anti-beta Galactosidase Antibody (Chicken) - Affinity Purified | Details |
| 11-Hydroxydrim-7-en-6-one | C15H24O2 | 74635-87-3 | Details |
| N-Methyl-1,2-phenylenediamine | C7H10N2 | 4760-34-3 | Details |
| N-Des-tetrahydrofuran N-(6,7-dimethoxy-4,4a-dihydroquinazolin-4-amine) alfuzosin-d3 | C24H30N8O4 | 928780-95-4 | Details |
| Trimethyl-1,3,5-triazinane-2,4,6-trione | C6H9N3O3 | 827-16-7 | Details |
| RuPhos Pd G3 | C43H57NO5PPdS- | 1445085-77-7 | Details |
| Oglemilast | C20H13Cl2F2N3O5S | 778576-62-8 | Details |
| Methyl 3-aminobenzoate | C8H9NO2 | 4518-10-9 | Details |
| (2S)-2-Amino-3-ethoxypropanoic acid hydrochloride | C5H12ClNO3 | 1311380-50-3 | Details |
| 4-Phenylbenzylamine | C13H13N | 712-76-5 | Details |
| [3-(2-Methylphenyl)-1,2,4-oxadiazol-5-yl]acetonitrile | C11H9N3O | 851208-00-9 | Details |
| Temozolomide acid | C6H5N5O3 | 113942-30-6 | Details |
| 1-Methyl-2-sulfanylidene-1,3-diazinane-4,6-dione | C5H6N2O2S | 15112-09-1 | Details |
| 6-Chloro-2-(chloromethyl)-4-phenyl-quinazoline | C15H10Cl2N2O | 5958-24-7 | Details |
| IQGAP3 antibody | Details |
| COVID-19 Nucleocapsid protein | Details |
| H-Arg(NO2)-pNA·HBr | C12H18BrN7O5 | 29028-61-3 | Details |
| 2-Amino-N,N-dimethyl-4-(methylsulfanyl)butanamide hydrochloride | 1955518-60-1 | Details |
| 1-Ethyl-2-(3-methylphenyl)-5-oxopyrrolidine-3-carboxylic acid | C14H17NO3 | 887361-19-5 | Details |
| 4-[3-(Trifluoromethyl)-3H-diazirin-3-yl]benzenemethanamine hydrochloride | C9H9ClF3N3 | 1258874-29-1 | Details |
| 1-(Bromomethyl)-3-isopropoxybenzene | C10H13BrO | 184970-27-2 | Details |
| TM5007 | C24H20N2O6S4 | 342595-05-5 | Details |
| 3'-Deoxyguanosine | C10H13N5O4 | 3608-58-0 | Details |
| 4,4-Dimethylcyclohexane-1-sulfonamide | C8H17NO2S | 1341720-23-7 | Details |
| ASMA Positive Human Plasma | Details |
| NR0B2 Blocking Peptide | Details |
| 1-Bromopentane | C5H11Br | 110-53-2 | Details |
| VCP antibody (Ser352) | Details |
| 3'-Methoxymirificin | C27H30O14 | 1297609-29-0 | Details |
| DYNC2LI1 antibody | Details |
| 2-Chloro-4-methoxy-3-methylpyridine | C7H8ClNO | 172152-57-7 | Details |
| ZNF700 antibody | Details |
| Quinoline-2,7-diamine | C9H9N3 | 114058-72-9 | Details |
| DDR2 antibody | Details |
| 2-Chloro-5-iodobenzene-1-sulfonamide | C6H5ClINO2S | 1261482-36-3 | Details |
| Tetrahydro-6-undecyl-2H-pyran-2-one | C16H30O2 | 7370-44-7 | Details |
| 4-[2-Amino-4-(trifluoromethyl)phenyl]-1λ?-thiomorpholine-1,1-dione | C11H13F3N2O2S | 861881-11-0 | Details |
| 1-Amino-3,3-dimethylcyclobutane-1-carboxylic acid hydrochloride | C7H14ClNO2 | 2171915-88-9 | Details |
| 2-{Bicyclo[2.2.1]heptan-2-yl}-3,4-dihydropyrimidin-4-one | C11H14N2O | 1565981-58-9 | Details |
| 5-Bromo-2-methyl-2H-1,2,3-triazole-4-carbaldehyde | C4H4BrN3O | 1306610-18-3 | Details |
| 2-Ethyl-6-phenoxy-1,4-dihydroquinolin-4-one | C17H15NO2 | 1155599-28-2 | Details |
| (3,5-Dibromo-4-chlorophenyl)methanol | C7H5Br2ClO | 1795347-29-3 | Details |
| cis-1,3-Cyclohexanediamine | C6H14N2 | 26772-34-9 | Details |
| 5-Phenyl-1,2-oxazol-3-ol | C9H7NO2 | 939-05-9 | Details |
| N-(3,5-bis(trifluoromethyl)phenyl)-2-(1-methylimidazol-2-ylthio)ethanamide | C14H11F6N3OS | 306732-34-3 | Details |
| FMO5 Blocking Peptide | Details |
| SMARCA3 Blocking Peptide | Details |
| 2-Chloro-N-methyl-4-nitrobenzamide | C8H7ClN2O3 | 90110-20-6 | Details |
| Undecylenyl b-D-maltoside | C23H42O11 | Details |
| 6-Chloro-5-methyl-2-(pyridin-2-yl)pyrimidin-4-amine | C10H9ClN4 | 2060034-38-8 | Details |
| PRMT1 antibody (HRP) | Details |
| 2-(tert-Butylamino)-N-(4-fluorophenyl)acetamide hydrochloride | C12H18ClFN2O | 1049751-65-6 | Details |
| 2-{2,5-Dioxo-3',4'-dihydro-2'H-spiro[imidazolidine-4,1'-naphthalen]-1-yl}acetic acid | C14H14N2O4 | 851170-88-2 | Details |
| (3-((hydroxyimino)ethyl)-4-methyl(2,5-thiazolyl))(3-(trifluoromethyl)phenyl)amine | C13H12F3N3OS | 1159976-73-4 | Details |
| HISPPD1 antibody | Details |
| 4,6-Dimethyl-5-nitro-1,2-dihydropyridin-2-one | C7H8N2O3 | 22934-24-3 | Details |
| HAV Total Antibody Positive Human Plasma | Details |
| N,N-Dimethyl-1-[(5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)sulfanyl]formamide | C13H15NO2S | 90401-89-1 | Details |
| Cyc-Biot-CGKGRGLC-NH2 | Details |
| (2E)-5-(tert-Butyloxycarbonylamino)-5-methylhex-2-enoic acid | C12H21NO4 | 181646-42-4 | Details |
| 2-Bromo-4-fluoro-N,N-dimethylbenzamide | C9H9BrFNO | 1016749-54-4 | Details |
| 3-(3-Bromo-4-fluorophenyl)cyclobutan-1-amine hydrochloride | C10H12BrClFN | 1807885-05-7 | Details |
| TAP1 Blocking Peptide | Details |
| 2-(3-Nitro-2-oxo-1,2-dihydropyridin-1-yl)acetic acid | C7H6N2O5 | 147283-78-1 | Details |
| Phaeochromycin C | C18H16O5 | 865795-54-6 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||